Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
Clinical trial NCT03218995 · COMPLETED
Trial details
- NCT number
- NCT03218995
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2021-03-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.